Aurélie Dumont

567 citations
9 papers · 229 indexed · h-index 6
Topics
Lung Cancer Treatments and Mutations (4 papers)Cancer-related Molecular Pathways (2 papers)Cancer Genomics and Diagnostics (2 papers)
Partner nations
FranceAustriaSwitzerland

In The Last Decade

Aurélie Dumont

9 papers receiving 228 citations

Peers

Aurélie Dumont
Comparison fields: 5 of 44
  • Molecular Biology 149
  • Oncology 80
  • Cancer Research 53
  • Pulmonary and Respiratory Medicine 43
  • Pathology and Forensic Medicine 34
Replace Anna A. Marusiak with:
Anna A. Marusiak Poland
Yangwei Fan China
Louise D. Johnson United Kingdom
Casey G. Langdon United States
Ilianna Zoi Greece
Shiyi Yu China
Atsutaka Masuda Japan
Bérengère Marty-Prouvost France
Tong Yu China
Stefanie Schrauwen Belgium
Aurélie Dumont relative to Anna A. Marusiak Poland Anna A. Marusiak's profile →
Citations per field
00.5×4.2×
Anna A. Marusiak · 1×
Citations per year

Countries citing papers authored by Aurélie Dumont

Since Specialization
Citations

This map shows the geographic impact of Aurélie Dumont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélie Dumont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélie Dumont more than expected).

Fields of papers citing papers by Aurélie Dumont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélie Dumont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélie Dumont. The network helps show where Aurélie Dumont may publish in the future.

Co-authorship network of co-authors of Aurélie Dumont

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélie Dumont. A scholar is included among the top collaborators of Aurélie Dumont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélie Dumont. Aurélie Dumont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 4
2 9
3 20
4 1
5 33
6 9
7 119
8 1
9 33

About Aurélie Dumont

Aurélie Dumont is a scholar working on Oncology, Cancer Research and Cell Biology, having authored 9 papers that have together received 229 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Cancer-related Molecular Pathways (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (53 citations), Oncology (80 citations) and Molecular Biology (149 citations). Aurélie Dumont has collaborated with scholars based in France, Austria and Switzerland. Frequent co-authors include Francisco Cruzalegui, Guillem Rigaill, Sergio Roman‐Roman, Gordon C. Tucker, David Gentien, Bérengère Marty-Prouvost, Bruno Tesson, Virginie Maire, Leanne de Koning and Thierry Dubois. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026